← Back to headlines
Bicara Therapeutics Reports GAAP EPS of -$0.68 and Releases Q4 Earnings Highlights
Bicara Therapeutics has announced its Generally Accepted Accounting Principles (GAAP) Earnings Per Share (EPS) at -$0.68, with Q4 earnings call highlights providing further details on its financial performance.
30 Mar, 13:19 — 30 Mar, 14:15
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: seeking-alpha · 30 Mar, 13:19|Full coverage: 2 · 56m|Window: 56m
Left-leaningCenterRight-leaning
